Abdul Mannan: Here’s when Your POC INR Machine Misleads You
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Your POC INR device will give you a number on a DOAC patient.
Confidently. Immediately. Completely useless.
This is one of the most common ward-level anticoagulation errors I see.
Here’s when your POC INR machine misleads you:
- Triple-positive APS (LA + aCL + anti-β2GPI): may dramatically underestimate true anticoagulation intensity
- DOACs: the device still displays a result. That result means nothing.
- Haematocrit below 25% or above 55%: mechanical detection methods are especially affected
- High paraprotein: viscosity throws off clot-based chemistries
Why does this happen?
Most modern POC devices (CoaguChek XS family) don’t measure fibrin formation. They measure thrombin generation via a synthetic substrate.
That’s the source of the interference.
Successive BSH and ISTH guidance has been explicit: Triple-positive APS patients must not be monitored with POC INR devices.
I’ve just published a free interactive reference covering all 5 major UK POC INR devices, the electrochemical principle (with an animated amperometric cell diagram), a full pre/post-analytical procedure, limitations taxonomy, and the safety non-negotiables.
Free to use, no login.
What’s the trickiest POC INR case you’ve had to escalate?”
Other posts from Abdul Mannan on Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering